PCA Dealing

Summary by AI BETAClose X

Tristel plc announced that Glenn Stephens, acting as a person closely associated with Non-Executive Director Caroline Stephens, purchased 2,310 ordinary shares at 389 pence per share on March 3, 2026. This transaction brings Caroline Stephens' total beneficial interest, including those held by her PCA, to 4,281 ordinary shares, representing approximately 0.01% of the company's issued share capital.

Disclaimer*

Tristel PLC
03 March 2026
 

A close-up of a logo Description automatically generated

 

Tristel plc

("Tristel" or the "Company")

 

PCA Dealing

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 3 March 2026 that Glenn Stephens, a PCA of Caroline Stephens, Non-Executive Director of the Company, purchased 2,310 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 389 pence per Ordinary Share.

 

Following the purchase, Caroline Stephens' beneficial interest in the Company, including those held by her PCA, is 4,281 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

 

For further information please contact:     

 

Tristel plc

Via Walbrook PR

Matt Sassone, Chief Executive Officer

www.investors.tristel.com

Anna Wasyl, Chief Financial Officer




Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus / Lianne Applegarth / Anna Dunphy  

Mob: 07980 541 893/ 07584 391 303/ 07876 741 001



Cavendish Capital Markets Ltd

Tel: 020 7220 0500

Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance)


Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)


 

A blue and purple sign with white text AI-generated content may be incorrect.


About Tristel plc

 

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre‑wetted plastic wipe.

 

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets delivering double-digit revenue growth annually, an adjusted EBITDA margin of at least 25% and a continuing progressive year-on-year growth in dividends, underpinned by robust cash generation. 

 

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit: https://tristel.com 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Glenn Stephens

2

 

Reason for the notification

 

a)

 

Position/status

 

PCA of Caroline Stephens, Non-Executive Director of the Company

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Tristel plc

b)

 

LEI

 

2138009DZ4LH9CZGF662

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

 

Ordinary Shares of 1p each in Tristel plc

 

 

 

GB00B07RVT99

b)

 

Nature of the transaction

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

389 pence

1,540

389 pence

770

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

2,310 Ordinary Shares of 1 penny each

 

389 pence

 

 

e)

 

Date of the transaction

 

3 March 2026

f)

 

Place of the transaction

 

London Stock Exchange (AIM)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Tristel (TSTL)
UK 100

Latest directors dealings